U.S. markets closed
  • S&P Futures

    4,377.25
    +0.75 (+0.02%)
     
  • Dow Futures

    34,893.00
    +18.00 (+0.05%)
     
  • Nasdaq Futures

    14,879.50
    +10.25 (+0.07%)
     
  • Russell 2000 Futures

    2,277.00
    -0.30 (-0.01%)
     
  • Crude Oil

    74.22
    +0.12 (+0.16%)
     
  • Gold

    1,807.90
    +2.00 (+0.11%)
     
  • Silver

    26.35
    +0.12 (+0.44%)
     
  • EUR/USD

    1.1869
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.3630
    +0.0070 (+0.52%)
     
  • Vix

    16.17
    -0.01 (-0.06%)
     
  • GBP/USD

    1.3894
    +0.0010 (+0.07%)
     
  • USD/JPY

    110.3070
    -0.0410 (-0.04%)
     
  • BTC-USD

    32,984.15
    -1,179.77 (-3.45%)
     
  • CMC Crypto 200

    805.44
    -40.19 (-4.75%)
     
  • FTSE 100

    7,125.42
    +3.54 (+0.05%)
     
  • Nikkei 225

    28,569.02
    0.00 (0.00%)
     

LAWSUITS FILED AGAINST FREQ, HMPT and DIDI - Jakubowitz Law Pursues Shareholders Claims

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / July 12, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Frequency Therapeutics, Inc. (NASDAQ:FREQ)

CONTACT JAKUBOWITZ ABOUT FREQ:
https://claimyourloss.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17587&from=1

Class Period: November 16, 2020 - March 22, 2021

Lead Plaintiff Deadline: August 2, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.

Home Point Capital Inc. (NASDAQ:HMPT)

CONTACT JAKUBOWITZ ABOUT HMPT:
https://claimyourloss.com/securities/home-point-capital-inc-loss-submission-form/?id=17587&from=1

This lawsuit is on behalf of all persons and entities other than Defendants that purchased or otherwise acquired Home Point common stock pursuant and/or traceable to the Company's January 29, 2021 initial public offering.

Lead Plaintiff Deadline: August 20, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Home Point's aggressive expansion of its broker partners would dramatically increase the Company's expenses; (ii) the mortgage industry was anticipating industry-wide decreased gain-on-sale margins as a result of rising interest rates in 2021 and Home Point would be subject to the same competitive pressures; (iii) accordingly, the Company had overstated its business and financial prospects; and (iv) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.

Didi Global Inc. F/K/A Xiaoju Kuaizhi Inc. (NYSE:DIDI)

CONTACT JAKUBOWITZ ABOUT DIDI:
https://claimyourloss.com/securities/didi-global-inc-f-k-a-xiaoju-kuaizhi-inc-loss-submission-form/?id=17587&from=1

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired DiDi American Depositary Shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's June 2021 initial public offering.

Lead Plaintiff Deadline: September 7, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) DiDi's apps did not comply with applicable laws and regulations governing privacy protection and the collection of personal information; (2) as a result, the Company was reasonably likely to incur scrutiny from the Cyberspace Administration of China; (3) the CAC had already warned DiDi to delay its IPO to conduct a self-examination of its network security; (4) as a result of the foregoing, DiDi's apps were reasonably likely to be taken down from app stores in China, which would have an adverse effect on its financial results and operations; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/655245/LAWSUITS-FILED-AGAINST-FREQ-HMPT-and-DIDI--Jakubowitz-Law-Pursues-Shareholders-Claims